Daewoong Pharmaceutical Co. Ltd.

This study aims to see if a new drug called DWZ2501 behaves the same way in the body as an existing drug (DWC202510) for patients with advanced ovarian cancer linked to a BRCA gene change. It will involve about 40 women who are already taking or need to start the existing drug. T…

This study aims to understand how three new drugs are absorbed and processed by the body and to check their safety. It involves 36 healthy adult volunteers who will take the drugs after a meal. This is an early-stage trial to gather basic information before testing in patients wi…

This early-stage study aims to understand how the body processes and tolerates three new drug compounds (DWJ1622, DWC202313, and DWC202314). It will enroll 40 healthy adult volunteers to measure drug levels in the blood and check for side effects. The main goal is to gather basic…